Validation of the current prognostic models for nonmetastatic renal cell carcinoma after nephrectomy in Chinese population: A 15-year single center experience

International Journal of Urology

Volumn 16, Issue 3, 2009, Pages 268-273

  Liu, Zheng ^a   Lv, Jiaju ^a   Ding, Kejia ^a   Fu, Qiang ^a   Cao, Qingwei ^a   Wang, Facheng ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Prognosis; Prognostic models; Renal cell carcinoma; Validation

Indexed keywords

ACCURACY; ADULT; AGED; ALGORITHM; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CHINESE; CLINICAL FEATURE; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NECROSIS; NEPHRECTOMY; NOMOGRAM; OVERALL SURVIVAL; PATHOLOGY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME; VALIDATION PROCESS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CAUSE OF DEATH; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEPHRECTOMY; POSTOPERATIVE COMPLICATIONS; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 62149131367     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2008.02229.x     Document Type: Article

References (25)

1. Kirkali Z, Tuzel E, Mungan MU. Recent advances in kidney cancer and metastatic disease. BJU Int. 2001 88 : 818 24.
2. Patard JJ, Tazi H, Bensalah K et al. The changing evolution of renal tumours: A single center experience over a two-decade period. Eur. Urol. 2004 45 : 490 4.
3. Figlin RA. Renal cell carcinoma: Management of advanced disease. J. Urol. 1999 161 : 381 7.
4. Huland E, Henzer H. Renal cell carcinoma: Novel treatments for advanced disease. Curr. Opin. Urol. 2003 13 : 451 6.
5. Guinan P, Sobin LH, Algaba F et al. TNM staging of renal cell carcinoma: Workgroup No. 3- Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997 80 : 992 3.
6. Kovacs G, Akhtar M, Beckwith BJ et al. The Heidelberg classification of renal cell tumours. J. Pathol. 1997 183 : 131 3.
7. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am. J. Surg. Pathol. 1982 6 : 655 63.
8. Kim HL, Seligson D, Liu X et al. Using protein expressions to predict survival in clear cell renal carcinoma. Clin. Cancer Res. 2004 10 : 5464 71.
9. Yaycioglu O, Roberts WW, Chan T et al. Prognostic assessment of nonmetastatic renal cell carcinoma: A clinically based model. Urology 2001 58 : 141 5.
10. Cindolo L, de La Taille A, Messina G et al. Preoperative clinical prognostic model for non-metastatic renal cell carcinoma. BJU Int. 2003 92 : 901 5.
11. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumour stage, size, grade and necrosis: The SSIGN score. J. Urol. 2002 168 : 2395 400.
12. Zisman A, Pantuck AJ, Dorey F et al. Mathematical model to predict individual survival for patients with renal cell carcinoma. J. Clin. Oncol. 2002 20 : 1368 74.
13. Kattan MW, Reuter V, Motzer RJ, Katz J, Russo P. A postoperative prognostic nomogram for renal cell carcinoma. J. Urol. 2001 166 : 63 7.
14. Sorbellini M, Kattan MW, Snyder ME et al. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J. Urol. 2005 173 : 48 51.
15. Karakiewicz PI, Briganti A, Chun FK et al. Multi-institutional validation of a new renal cancer-specific survival nomogram. J. Clin. Oncol. 2007 25 : 1316 22.
16. Cindolo L, Patard JJ, Chiodini P et al. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: A multicenter European study. Cancer 2005 104 : 1362 71.
17. Harrell FE Jr., Lee KL, Mark DB. Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat. Med. 1996 15 : 361 87.
18. Harrell FE Jr., Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA 1982 247 : 2543 6.
19. Harrell F. Regression Modeling Strategies: With Application to Linear Models, Logistic Regression, and Survival Analysis. Springer-Verlag, New York, 2001.
20. Karakiewicz PI, Suardi N, Capitanio U et al. A Preoperative Prognostic Model for Patients Treated with Nephrectomy for Renal Cell Carcinoma. Eur. Urol. 2008 Epub ahead of print], doi: 10.1016/j.euroro.2008.07.037
21. Hupertan V, Roupret M, Poisson JF et al. Low predictive accuracy of the Kattan postoperative nomogram for renal cell carcinoma recurrence in a population of French patients. Cancer 2006 107 : 2604 8.
22. Patard JJ, Kim HL, Lam JS et al. Use of the University of California Los Angeles Integrated Staging System to predict survival in renal cell carcinoma: An international multicenter study. J. Clin. Oncol. 2004 22 : 3316 22.
23. Cindolo L, Chiodini P, Gallo C et al. Validation by calibration of the UCLA integrated staging system prognostic model for nonmetastatic renal cell carcinoma after nephrectomy. Cancer 2008 113 : 65 71.
24. Zisman A, Pantuck AJ, Wieder J et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J. Clin. Oncol. 2002 20 : 4559 66.
25. Kim HL, Seligson D, Liu X et al. Using protein expressions to predict survival in clear cell renal carcinoma. Clin. Cancer Res. 2004 10 : 5464 71.